Avid Radiopharmaceuticals

Founded in 2003, United BioSource Corporation, also known as UBC, is a pharmaceutical service organization that helps life science companies to develop and commercialize medical products. With offices in the United States, Canada, Eastern and Western Europe and South America, it employs more than 1, 200 professionals in over 20 countries. The company offers risk management, site support and e-learning solutions. It provides biostatistics and data management, clinical development and patient-reported outcomes training services. United BioSource Corporation conducts health outcomes research activities and prepares meta-analysis and systematic reviews. The company has a staff of scientists who provide consulting services in the areas of protocol writing, data management, site identification, and patient recruitment and retention.

Founded in 1999, GENEWIZ Inc. is a global contract research organization providing deoxyribonucleic acid (DNA) services. Based in South Plainfield, N.J., the firm offers a range of services, such as DNA sequencing, gene synthesis, molecular biology and genomic services. Its Good Laboratory Practice (GLP) services include double strand sequence confirmation, primer walking, nucleic acid extraction and reverse transcription polymerase chain reaction and sequencing. GENEWIZ Inc. caters to numerous market segments, including academic, pharmaceutical, clinical, biotechnology and government institutions.

ICON Clinical Research, based in North Wales, PA, is a premier Contract Research Organisation that offers a comprehensive range of clinical consulting and commercial services across multiple sectors, including biotech, pharmaceuticals, and medical devices. With a focus on innovative and patient-centric solutions, ICON is dedicated to advancing drug development through strategic partnerships and cutting-edge technologies. The company specializes in various therapeutic areas, providing tailored support for the unique needs of clients, including early clinical solutions, cardiac safety, and market access expertise. ICON is committed to enhancing research and development return on investment while actively contributing to community well-being through its ICON Cares program, which emphasizes sustainability and social responsibility. Generated from the website